Filtros : "Indexado na Base de Dados Chemical Abstracts" "WRENGER, CARSTEN" Limpar

Filtros



Limitar por data


  • Fonte: Biochemical and Biophysical Research Communications. Unidade: ICB

    Assuntos: PARASITOLOGIA, PLASMODIUM FALCIPARUM, MALÁRIA

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LUNEV, Sergey et al. Identification of a non-competitive inhibitor of Plasmodium falciparum aspartate transcarbamoylase. Biochemical and Biophysical Research Communications, v. 497, n. 3, p. 835-842, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.bbrc.2018.02.112. Acesso em: 01 out. 2024.
    • APA

      Lunev, S., Bosch, S. S., Batista, F. A., Wang, C., Li, J., Linzke, M., et al. (2018). Identification of a non-competitive inhibitor of Plasmodium falciparum aspartate transcarbamoylase. Biochemical and Biophysical Research Communications, 497(3), 835-842. doi:10.1016/j.bbrc.2018.02.112
    • NLM

      Lunev S, Bosch SS, Batista FA, Wang C, Li J, Linzke M, Kruithof P, Chamoun G, Domling ASS, Wrenger C, Groves MR. Identification of a non-competitive inhibitor of Plasmodium falciparum aspartate transcarbamoylase [Internet]. Biochemical and Biophysical Research Communications. 2018 ; 497(3): 835-842.[citado 2024 out. 01 ] Available from: https://doi.org/10.1016/j.bbrc.2018.02.112
    • Vancouver

      Lunev S, Bosch SS, Batista FA, Wang C, Li J, Linzke M, Kruithof P, Chamoun G, Domling ASS, Wrenger C, Groves MR. Identification of a non-competitive inhibitor of Plasmodium falciparum aspartate transcarbamoylase [Internet]. Biochemical and Biophysical Research Communications. 2018 ; 497(3): 835-842.[citado 2024 out. 01 ] Available from: https://doi.org/10.1016/j.bbrc.2018.02.112
  • Fonte: Biomolecules. Unidade: ICB

    Assuntos: PARASITOLOGIA, ÁCIDOS NUCLEICOS, MODELAGEM MOLECULAR, MOLÉCULA

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      KRÜGER, Arne et al. Molecular modeling applied to nucleic acid-based molecule development. Biomolecules, v. 8, n. 3, p. 1-17, 2018Tradução . . Disponível em: https://doi.org/10.3390/biom8030083. Acesso em: 01 out. 2024.
    • APA

      Krüger, A., Zimbres, F. M., Kronenberger, T., & Wrenger, C. (2018). Molecular modeling applied to nucleic acid-based molecule development. Biomolecules, 8( 3), 1-17. doi:10.3390/biom8030083
    • NLM

      Krüger A, Zimbres FM, Kronenberger T, Wrenger C. Molecular modeling applied to nucleic acid-based molecule development [Internet]. Biomolecules. 2018 ; 8( 3): 1-17.[citado 2024 out. 01 ] Available from: https://doi.org/10.3390/biom8030083
    • Vancouver

      Krüger A, Zimbres FM, Kronenberger T, Wrenger C. Molecular modeling applied to nucleic acid-based molecule development [Internet]. Biomolecules. 2018 ; 8( 3): 1-17.[citado 2024 out. 01 ] Available from: https://doi.org/10.3390/biom8030083
  • Fonte: PLOS ONE. Unidade: ICB

    Assuntos: PARASITOLOGIA, PLASMODIUM FALCIPARUM, MALÁRIA

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LUNEV, Sergey et al. Oligomeric interfaces as a tool in drug discovery: Specific interference with activity of malate dehydrogenase of Plasmodium falciparum in vitro. PLOS ONE, v. 13, n. 4, p. e0195011, 2018Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0195011. Acesso em: 01 out. 2024.
    • APA

      Lunev, S., Butzloff, S., Romero, A. R., Linzke, M., Batista, F. A., Meissner, K. A., et al. (2018). Oligomeric interfaces as a tool in drug discovery: Specific interference with activity of malate dehydrogenase of Plasmodium falciparum in vitro. PLOS ONE, 13( 4), e0195011. doi:10.1371/journal.pone.0195011
    • NLM

      Lunev S, Butzloff S, Romero AR, Linzke M, Batista FA, Meissner KA, Müller IB, Adawy A, Wrenger C, Groves MR. Oligomeric interfaces as a tool in drug discovery: Specific interference with activity of malate dehydrogenase of Plasmodium falciparum in vitro [Internet]. PLOS ONE. 2018 ;13( 4): e0195011.[citado 2024 out. 01 ] Available from: https://doi.org/10.1371/journal.pone.0195011
    • Vancouver

      Lunev S, Butzloff S, Romero AR, Linzke M, Batista FA, Meissner KA, Müller IB, Adawy A, Wrenger C, Groves MR. Oligomeric interfaces as a tool in drug discovery: Specific interference with activity of malate dehydrogenase of Plasmodium falciparum in vitro [Internet]. PLOS ONE. 2018 ;13( 4): e0195011.[citado 2024 out. 01 ] Available from: https://doi.org/10.1371/journal.pone.0195011
  • Fonte: Chemical Biology and Drug Design. Unidades: FCF, ICB

    Assuntos: PLASMODIUM FALCIPARUM, PARASITOLOGIA, MALÁRIA, QUIMIOTERAPIA, ENZIMAS PROTEOLITICAS, ATIVAÇÃO ENZIMÁTICA

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MEISSNER, Kamila Anna et al. Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening. Chemical Biology and Drug Design, v. 2018 p. 1-13, 2018Tradução . . Disponível em: https://doi.org/10.1111/cbdd.13416. Acesso em: 01 out. 2024.
    • APA

      Meissner, K. A., Kronenberger, T., Maltarollo, V. G., Trossini, G. H. G., & Wrenger, C. (2018). Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening. Chemical Biology and Drug Design, 2018 p. 1-13. doi:10.1111/cbdd.13416
    • NLM

      Meissner KA, Kronenberger T, Maltarollo VG, Trossini GHG, Wrenger C. Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening [Internet]. Chemical Biology and Drug Design. 2018 ; 2018 p. 1-13[citado 2024 out. 01 ] Available from: https://doi.org/10.1111/cbdd.13416
    • Vancouver

      Meissner KA, Kronenberger T, Maltarollo VG, Trossini GHG, Wrenger C. Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening [Internet]. Chemical Biology and Drug Design. 2018 ; 2018 p. 1-13[citado 2024 out. 01 ] Available from: https://doi.org/10.1111/cbdd.13416
  • Fonte: Current Medicinal Chemistry. Unidade: ICB

    Assunto: PARASITOLOGIA

    Como citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PEREIRA, C. A. et al. Metabolite transporters in trypanosomatid parasites: promising therapeutic targets but.. how to deal with them?. Current Medicinal Chemistry, v. 21, n. 15, p. 1707-1712, 2014Tradução . . Acesso em: 01 out. 2024.
    • APA

      Pereira, C. A., Mayé, M., Wrenger, C., & Miranda, M. R. (2014). Metabolite transporters in trypanosomatid parasites: promising therapeutic targets but.. how to deal with them? Current Medicinal Chemistry, 21( 15), 1707-1712.
    • NLM

      Pereira CA, Mayé M, Wrenger C, Miranda MR. Metabolite transporters in trypanosomatid parasites: promising therapeutic targets but.. how to deal with them? Current Medicinal Chemistry. 2014 ; 21( 15): 1707-1712.[citado 2024 out. 01 ]
    • Vancouver

      Pereira CA, Mayé M, Wrenger C, Miranda MR. Metabolite transporters in trypanosomatid parasites: promising therapeutic targets but.. how to deal with them? Current Medicinal Chemistry. 2014 ; 21( 15): 1707-1712.[citado 2024 out. 01 ]
  • Fonte: BioMed Research International. Unidade: ICB

    Assunto: PARASITOLOGIA

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DITGEN, Dana et al. Harnessing the helminth secretome for therapeutic immunomodulators. BioMed Research International, v. 2014, p. 1-14, 2014Tradução . . Disponível em: https://doi.org/10.1155/2014/964350. Acesso em: 01 out. 2024.
    • APA

      Ditgen, D., Anandarajah, E. M., Meissner, K. A., Bratting, N., Wrenger, C., & Liebau, E. (2014). Harnessing the helminth secretome for therapeutic immunomodulators. BioMed Research International, 2014, 1-14. doi:10.1155/2014/964350
    • NLM

      Ditgen D, Anandarajah EM, Meissner KA, Bratting N, Wrenger C, Liebau E. Harnessing the helminth secretome for therapeutic immunomodulators [Internet]. BioMed Research International. 2014 ; 2014 1-14.[citado 2024 out. 01 ] Available from: https://doi.org/10.1155/2014/964350
    • Vancouver

      Ditgen D, Anandarajah EM, Meissner KA, Bratting N, Wrenger C, Liebau E. Harnessing the helminth secretome for therapeutic immunomodulators [Internet]. BioMed Research International. 2014 ; 2014 1-14.[citado 2024 out. 01 ] Available from: https://doi.org/10.1155/2014/964350
  • Fonte: Current Medicinal Chemistry. Unidade: ICB

    Assunto: PARASITOLOGIA

    Como citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DREBES, Julia et al. MRSA infections: from classical treatment to suicide drugs. Current Medicinal Chemistry, v. 21, n. 15, p. 1809-1819, 2014Tradução . . Acesso em: 01 out. 2024.
    • APA

      Drebes, J., Künz, M., Pereira, C. A., Betzel, C., & Wrenger, C. (2014). MRSA infections: from classical treatment to suicide drugs. Current Medicinal Chemistry, 21( 15), 1809-1819.
    • NLM

      Drebes J, Künz M, Pereira CA, Betzel C, Wrenger C. MRSA infections: from classical treatment to suicide drugs. Current Medicinal Chemistry. 2014 ; 21( 15): 1809-1819.[citado 2024 out. 01 ]
    • Vancouver

      Drebes J, Künz M, Pereira CA, Betzel C, Wrenger C. MRSA infections: from classical treatment to suicide drugs. Current Medicinal Chemistry. 2014 ; 21( 15): 1809-1819.[citado 2024 out. 01 ]
  • Fonte: Future Medicinal Chemistry. Unidade: ICB

    Assunto: PARASITOLOGIA

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      KRONENBERGER, Thales e SCHETTERT, Isolmar e WRENGER, Carsten. Targeting the vitamin biosynthesis pathways for the treatment of malaria. Future Medicinal Chemistry, v. 5, n. 7, p. 769-779, 2013Tradução . . Disponível em: https://doi.org/10.4155/FMC.13.43. Acesso em: 01 out. 2024.
    • APA

      Kronenberger, T., Schettert, I., & Wrenger, C. (2013). Targeting the vitamin biosynthesis pathways for the treatment of malaria. Future Medicinal Chemistry, 5( 7), 769-779. doi:10.4155/FMC.13.43
    • NLM

      Kronenberger T, Schettert I, Wrenger C. Targeting the vitamin biosynthesis pathways for the treatment of malaria [Internet]. Future Medicinal Chemistry. 2013 ; 5( 7): 769-779.[citado 2024 out. 01 ] Available from: https://doi.org/10.4155/FMC.13.43
    • Vancouver

      Kronenberger T, Schettert I, Wrenger C. Targeting the vitamin biosynthesis pathways for the treatment of malaria [Internet]. Future Medicinal Chemistry. 2013 ; 5( 7): 769-779.[citado 2024 out. 01 ] Available from: https://doi.org/10.4155/FMC.13.43

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2024